We are live on ! Find out more
BIOC

Biocept, Inc.
BIOC

Delisted

BIOC was delisted on the 24th of October, 2023.

Back to rankings

6 hedge funds and large institutions have $455K invested in Biocept, Inc. in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

43% less capital invested

Capital invested by funds: $803K → $455K (-$348K)

45% less funds holding

Funds holding: 11 → 6 (-5)

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Holders
6
Holders Change
-5
Holders Change %
-45.45%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$16.3K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$16.3K

Top Sellers

Rank Fund Capital Flow
1
Creative Planning
Creative Planning
Kansas
-$81.6K
2
AFM
Anson Funds Management
Texas
-$74K
3
CC
Callan Capital
California
-$25K
4
UBS Group
UBS Group
Switzerland
-$16.3K
5
Northern Trust
Northern Trust
Illinois
-$14K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$227K +$16.3K +1 +7%
BIT
2
BlackRock Institutional Trust
California
$89K – – –
GBA
3
Garrison Bradford & Associates
New York
$59K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$43K – – –
Citadel Advisors
5
Citadel Advisors
Florida
$18K +$16.3K +1 New
Creative Planning
6
Creative Planning
Kansas
$8K -$81.6K -5 -83%
UBS Group
7
UBS Group
Switzerland
$6K -$16.3K -1 Closed
BFA
8
BlackRock Fund Advisors
California
$2K – – –
ASN
9
Advisory Services Network
Georgia
$1K – – –
LTFS
10
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Morgan Stanley
11
Morgan Stanley
New York
$1K – – –
AFM
12
Anson Funds Management
Texas
– -$74K -4 Closed
CC
13
Callan Capital
California
– -$25K -1 Closed
Goldman Sachs
14
Goldman Sachs
New York
– -$11K -1 Closed
MWM
15
Merriman Wealth Management
Washington
– -$12K -1 Closed
Northern Trust
16
Northern Trust
Illinois
– -$14K -1 Closed
SCM
17
Sterneck Capital Management
Missouri
– -$7K – –
TSS
18
Two Sigma Securities
New York
– -$7K – –

BIOC Hedge Fund Activity: Q3 2016 in Review

6 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q3 2016, worth a combined $455K — down 43% from $803K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of BIOC and 1 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $16.3K. The largest seller was Creative Planning, cutting an estimated $81.6K.

  • 6 institutional investors held Biocept, Inc. (BIOC) as of Q3 2016, down from 11 in Q2 2016.
  • Funds reported $455K of Biocept, Inc. stock for Q3 2016, down 43% quarter-over-quarter.
  • 1 fund opened new Biocept, Inc. positions in Q3 2016 and 6 closed out, a net change of -5 holders.
  • The largest Biocept, Inc. buyer in Q3 2016 was Citadel Advisors, an estimated $16.3K added.
  • The largest Biocept, Inc. seller in Q3 2016 was Creative Planning, an estimated $81.6K sold.

Based on aggregated 13F filings for Q3 2016.